» Articles » PMID: 10871255

Epstein-Barr Virus and the Nervous System

Overview
Specialty Neurology
Date 2000 Jun 28
PMID 10871255
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The neurological complications of Epstein-Barr virus infection include viral meningitis, encephalitis and neuromuscular complications. The introduction of cerebrospinal fluid polymerase chain reaction for Epstein-Barr virus DNA has improved diagnosis of these conditions and of primary central nervous system lymphoma in acquired immune deficiency syndrome, and has enabled cerebrospinal fluid monitoring of therapy. Prognosis remains good for most Epstein-Barr virus-related neurological complications; for primary central nervous system lymphoma in acquired immune deficiency syndrome the prognosis is still poor.

Citing Articles

Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities.

Obraitis D, Li D Curr Opin Virol. 2024; 68-69:101437.

PMID: 39537445 PMC: 11795702. DOI: 10.1016/j.coviro.2024.101437.


EBV-associated CNS infection in an immunocompetent adult: A case report and literature review.

Srifuengfung G, Suppakitjanusant P, Chaisrimaneepan N Clin Case Rep. 2024; 12(3):e8568.

PMID: 38444918 PMC: 10912102. DOI: 10.1002/ccr3.8568.


Neurological Spectrum of Epstein-Barr Virus Infection: A Rare Clinical Case.

Gomes D, Andre R, Oliveira C, Camoes S, Silva C, Mendes M Cureus. 2024; 16(1):e53302.

PMID: 38435902 PMC: 10906542. DOI: 10.7759/cureus.53302.


Epstein-Barr Virus Encephalitis Presenting As Acute Disseminated Encephalomyelitis: A Challenging Diagnostic Dilemma.

Pandey N, Chawala A, Kandhi S, Dhallu M, Chilimuri S Cureus. 2023; 15(11):e48277.

PMID: 38058351 PMC: 10695853. DOI: 10.7759/cureus.48277.


The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?.

Lage L, Araujo Soares V, Meneguin T, Culler H, Reichert C, Jacomassi M Radiat Oncol. 2022; 17(1):171.

PMID: 36273167 PMC: 9588209. DOI: 10.1186/s13014-022-02142-y.